Natco Pharma Ltd
Professor M U R Naidu, Former Dean faculty of medicine and head of the department of Clinical pharmacology and therapeutic at Nizam’s Institute of medical sciences Hyderabad, has completed his medical post-graduation MD, from Jabalpur medical college in 1977. He received advanced professional training in clinical pharmacology in UK, Germany and USA. Dr. Naidu had received WHO Fellowship for advanced training on ADR Monitoring, at Uppsala, Sweden.
He is well known clinical pharmacologist with more than 40 years of teaching and research experience. His main area of interest is clinical research especially cardiovascular system and phase 1 clinical trial. Dr. Naidu has made significant contribution in developing noninvasive methods in clinical pharmacology. He traveled extensively to many countries and was invited as guest speaker in many international conferences.
This person is not in the org chart
This person is not in any teams
This person is not in any offices
Natco Pharma Ltd
2 followers
Natco Pharma Limited is a pharmaceutical company. The Company is engaged in developing, manufacturing and marketing finished dosage formulations (FDF) and active pharmaceutical ingredients (APIs). The Company's segments include active pharmaceuticals ingredient, finished dosage formulations, job works, pharmacy and others. The Company's product categories include Domestic Formulations, International Formulations, API's and Blockbusters. The Company's products include Alphalan, Bandrone, Bendit, Clokeran, Lenalid, Thioplan, Anastronat, Capnat, Fulvenat, Kabanat, Natdox-LP, Rapact, Temonat, X-Trant, Glatimer, Hepcinat, Natdac, Natzold, Tigi, Alprazolam, Chloroquine Phosphate, Lansoprazole, Letrozole, Granisetron, Rizatriptan IR, Imatinib, Salmeterol Xinafoate, Sertraline Form I, Ibandronate Sodium Monohydrate, Pantoprazole Sodium Sesquihydrate, Ondansetron Hydrochloride (Injectable Grade), Daclatasvir and Glatiramer Acetate. The Company manufactures over 20 products under contract.